Document Detail

The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels.
MedLine Citation:
PMID:  6426568     Owner:  NLM     Status:  MEDLINE    
Helically cut strips of rabbit aorta, extrapulmonary artery, coeliac artery, and femoral artery were set up in organ baths. Contractions of the strips by noradrenaline and angiotensin II were recorded isotonically. The release of prostaglandins 6-keto-PGF1 alpha, E2, F2 alpha, D2 and thromboxane B2 from the strips was measured by means of sensitive and specific radioimmunoassays. All blood vessels released a characteristic pattern of cyclo-oxygenase products. Prostacyclin (PGI2, measured as 6-keto-PGF1 alpha) was the major compound formed, followed by smaller amounts of PGE2 and traces of PGF2 alpha, PGD2 and thromboxane A2 (measured as thromboxane B2). The pulmonary and the femoral artery had comparatively high abilities to synthesize PGE2. Contractions induced by noradrenaline increased prostaglandin release from the pulmonary artery but not from the other blood vessels. Angiotensin II-induced contractions were accompanied by a marked prostaglandin release from the coeliac artery. After angiotensin II, prostaglandin release was also enhanced in the pulmonary artery, but remained essentially unchanged in the aorta and femoral artery. Arachidonic acid markedly increased the levels of all prostaglandin formed. Indomethacin inhibited the formation of all prostaglandins below the detection limits of the respective radioimmunoassays. Indomethacin treatment induced a qualitatively similar shifting of the concentration-response curves of noradrenaline and angiotensin II in some vessels: the concentration-response curves remained unchanged for the aorta, were slightly shifted to the left of the pulmonary artery, were markedly shifted to the left for the coeliac artery, and were shifted to the right for the femoral artery. 7 Exogenous PGI2 strongly and concentration-dependently inhibited contractions induced by the approximate EC50 of noradrenaline in the coeliac artery, but was without effect on the other three preparations. PGE2 had no effect on noradrenaline-induced contractions of the aorta, inhibited those of the pulmonary and the coeliac artery, but markedly potentiated those of the femoral artery. PGF2 alpha significantly enhanced contractions of the femoral artery, but increased contractions of the other preparations were not significant. PGD2 was without effect on any preparation. 8 In conclusion, the contractility of the aorta does not seem to be modulated substantially by prostaglandins. The major prostanoid regulating the tone of the coeliac artery was found to be PGI2. The contractility of the pulmonary and especially the femoral artery is probably not modulated by PGI2 but rather by PGE2. 9 These observations suggest that in certain blood vessels, prostaglandins other than PGI2 are important endogenous modulators of contractility.
U F?rstermann; G Hertting; B Neufang
Related Documents :
16534188 - Relaxant effects of the soluble guanylate cyclase activator and no sensitizer yc-1 in p...
2540318 - Postjunctional alpha-1 and alpha-2 adrenoceptors in human skin arteries. an in vitro st...
15829438 - The contracting and relaxing responses of human internal mammary artery grafts harveste...
8557898 - Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition ...
24029088 - Endovascular treatment of a1 aneurysms. a series of five cases with a brief literature ...
21981808 - Circulating endothelial progenitor cells and large artery structure and function in you...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  81     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  1984 Apr 
Date Detail:
Created Date:  1984-07-18     Completed Date:  1984-07-18     Revised Date:  2010-05-19    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  623-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II / pharmacology
Arteries / physiology*
Cyclooxygenase Inhibitors*
Epoprostenol / pharmacology,  physiology
Indomethacin / pharmacology*
Muscle Contraction / drug effects
Muscle, Smooth, Vascular / physiology*
Norepinephrine / pharmacology
Prostaglandins / pharmacology,  physiology*
Prostaglandins E / pharmacology,  physiology
Reg. No./Substance:
0/Cyclooxygenase Inhibitors; 0/Prostaglandins; 0/Prostaglandins E; 11128-99-7/Angiotensin II; 35121-78-9/Epoprostenol; 363-24-6/Dinoprostone; 51-41-2/Norepinephrine; 53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypercapnia during maximal exercise in patients with chronic airflow obstruction.
Next Document:  Stereotactic heavy-ion Bragg peak radiosurgery for intra-cranial vascular disorders: method for trea...